BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16914291)

  • 1. The neuropeptide pituitary adenylate cyclase activating protein stimulates human monocytes by transactivation of the Trk/NGF pathway.
    El Zein N; Badran BM; Sariban E
    Cell Signal; 2007 Jan; 19(1):152-62. PubMed ID: 16914291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
    El Zein N; Badran B; Sariban E
    Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalks between the receptors tyrosine kinase EGFR and TrkA and the GPCR, FPR, in human monocytes are essential for receptors-mediated cell activation.
    El Zein N; D'Hondt S; Sariban E
    Cell Signal; 2010 Oct; 22(10):1437-47. PubMed ID: 20566383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuropeptide pituitary adenylate cyclase activating protein is a physiological activator of human monocytes.
    El Zein N; Corazza F; Sariban E
    Cell Signal; 2006 Feb; 18(2):162-73. PubMed ID: 15993038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and modulation of pituitary adenylate cyclase-activating protein-induced calcium mobilization in human neutrophils.
    Harfi I; Sariban E
    Ann N Y Acad Sci; 2006 Jul; 1070():322-9. PubMed ID: 16888186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting neurotrophic effects by GPCR ligands.
    Jeanneteau F; Chao MV
    Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous upregulation of nerve growth factor-TrkA receptors in PC12 cells by pituitary adenylate cyclase-activating polypeptide (PACAP).
    Lazarovici P; Fink D
    Mol Cell Biol Res Commun; 1999 Aug; 2(2):97-102. PubMed ID: 10542132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TrkA as a life and death receptor: receptor dose as a mediator of function.
    Yan C; Liang Y; Nylander KD; Schor NF
    Cancer Res; 2002 Sep; 62(17):4867-75. PubMed ID: 12208732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve growth factor regulates substance P in adult sensory neurons through both TrkA and p75 receptors.
    Skoff AM; Adler JE
    Exp Neurol; 2006 Feb; 197(2):430-6. PubMed ID: 16300761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory effect of pituitary adenylate-cyclase activating polypeptide (PACAP) and its PACAP type I receptor (PAC1R) on prolactin synthesis in rat pituitary somatolactotroph GH3 cells.
    Mijiddorj T; Kanasaki H; Purwana IN; Oride A; Miyazaki K
    Mol Cell Endocrinol; 2011 Jun; 339(1-2):172-9. PubMed ID: 21539889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides.
    Lee FS; Rajagopal R; Kim AH; Chang PC; Chao MV
    J Biol Chem; 2002 Mar; 277(11):9096-102. PubMed ID: 11784714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src-dependent TrkA transactivation is required for pituitary adenylate cyclase-activating polypeptide 38-mediated Rit activation and neuronal differentiation.
    Shi GX; Jin L; Andres DA
    Mol Biol Cell; 2010 May; 21(9):1597-608. PubMed ID: 20219970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRKing signals through the Golgi.
    Sorkin A
    Sci STKE; 2005 Jan; 2005(267):pe1. PubMed ID: 15657262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1.
    El Zein N; Badran B; Sariban E
    J Leukoc Biol; 2008 Apr; 83(4):972-81. PubMed ID: 18174366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells.
    Falluel-Morel A; Chafai M; Vaudry D; Basille M; Cazillis M; Aubert N; Louiset E; de Jouffrey S; Le Bigot JF; Fournier A; Gressens P; Rostène W; Vaudry H; Gonzalez BJ
    J Neuroendocrinol; 2007 May; 19(5):321-7. PubMed ID: 17425606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nerve growth factor-induced retrograde survival signal mediated by mechanisms downstream of TrkA.
    Mok SA; Campenot RB
    Neuropharmacology; 2007 Feb; 52(2):270-8. PubMed ID: 16949623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A food-derived synergist of NGF signaling: identification of protein tyrosine phosphatase 1B as a key regulator of NGF receptor-initiated signal transduction.
    Shibata T; Nakahara H; Kita N; Matsubara Y; Han C; Morimitsu Y; Iwamoto N; Kumagai Y; Nishida M; Kurose H; Aoki N; Ojika M; Uchida K
    J Neurochem; 2008 Dec; 107(5):1248-60. PubMed ID: 18796006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive Intestinal Peptide and pituary adenylate cyclase-activating polypeptide inhibit tissue factor expression in monocyte in vitro and in vivo.
    Lv B; Tang Y; Chen F; Xiao X
    Shock; 2009 Feb; 31(2):185-91. PubMed ID: 18650785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.